Medivolve Inc. (MEDVF)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Sep 1, 2026, 4:00 PM EST
Medivolve Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 1, 2026 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| 0 | 0 | 3 | 24 | 48 | 3 | |
Market Cap Growth | 9907.41% | -88.49% | -89.24% | -50.25% | 1620.39% | -17.95% |
Enterprise Value | - | 0 | -1 | 24 | 43 | 2 |
Last Close Price | 0.00 | 0.01 | 0.09 | 0.88 | 4.80 | 1.22 |
Price Ratios
Fiscal Year | Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 1, 2026 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
PS Ratio | 0.00 | 0.57 | 2.49 | 0.35 | 5.76 | - |
PB Ratio | 0.00 | -0.02 | 10.61 | 1.69 | -6.08 | 1.82 |
P/TBV Ratio | - | - | - | 1.95 | - | 1.82 |
P/FCF Ratio | - | - | 0.57 | - | - | - |
P/OCF Ratio | - | - | 0.57 | - | - | - |
EV Ratios
Fiscal Year | Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 1, 2026 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
EV/Sales Ratio | - | 0.30 | - | 0.35 | 5.12 | - |
EV/EBITDA Ratio | - | - | - | 2.64 | - | - |
EV/EBIT Ratio | - | - | - | 2.89 | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 1, 2026 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Debt / Equity Ratio | -0.10 | -0.10 | 4.99 | 0.10 | -2.02 | - |
Debt / EBITDA Ratio | - | - | - | 0.12 | - | - |
Debt / FCF Ratio | - | - | 0.27 | - | - | - |
Net Debt / Equity Ratio | -0.07 | -0.04 | -8.11 | 0.10 | -1.89 | -0.19 |
Net Debt / EBITDA Ratio | -0.44 | -0.20 | 0.20 | 0.15 | -1.95 | - |
Net Debt / FCF Ratio | -1.11 | -0.23 | -0.44 | -0.20 | -1.66 | 0.16 |
Asset Turnover | 0.11 | 0.07 | 0.04 | 2.21 | 0.99 | - |
Inventory Turnover | 3.26 | 0.78 | 1.57 | 161.75 | - | - |
Quick Ratio | 0.04 | 0.07 | 0.90 | 1.37 | 0.08 | 2.22 |
Current Ratio | 0.05 | 0.08 | 0.95 | 1.38 | 0.16 | 6.08 |
Return on Equity (ROE) | - | - | -160.78% | -169.62% | - | -83.25% |
Return on Assets (ROA) | -22.74% | -20.13% | -20.98% | 16.84% | -57.36% | -42.84% |
Return on Capital Employed (ROCE) | 16.70% | 21.50% | -1151.30% | 56.30% | 98.20% | -118.80% |
Yields
Fiscal Year | Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 1, 2026 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Earnings Yield | -395696.48% | -4231.49% | -530.33% | -21.96% | -62.00% | -75.40% |
FCF Yield | -30321.72% | -743.98% | 174.54% | -27.78% | -18.70% | -68.20% |
Buyback Yield / Dilution | -0.01% | -0.01% | -39.81% | -189.58% | -192.76% | - |